Trial intelligence / Profile preview

Remifentanil for CVC Insertion

NCT02206022Phase 4Completed

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Aug 2014
Primary completion
Dec 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of remifentanil in procedural pain, sponsored by Centre hospitalier universitaire de Toulouse. Started Aug 2014; status: completed.

02

Drugs

remifentanil
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT02206022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02206022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call